Amgen Net Income 2006-2020 | AMGN

Amgen annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending December 31, 2020 was $1.615B, a 5.17% decline year-over-year.
  • Amgen net income for the twelve months ending December 31, 2020 was $7.264B, a 7.37% decline year-over-year.
  • Amgen annual net income for 2020 was $7.264B, a 7.37% decline from 2019.
  • Amgen annual net income for 2019 was $7.842B, a 6.58% decline from 2018.
  • Amgen annual net income for 2018 was $8.394B, a 324.15% increase from 2017.
Amgen Annual Net Income
(Millions of US $)
2020 $7,264
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
2008 $4,052
2007 $3,078
2006 $2,950
2005 $3,674
Amgen Quarterly Net Income
(Millions of US $)
2020-12-31 $1,615
2020-09-30 $2,021
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
2008-12-31 $925
2008-09-30 $1,121
2008-06-30 $906
2008-03-31 $1,100
2007-12-31 $747
2007-09-30 $201
2007-06-30 $1,019
2007-03-31 $1,111
2006-12-31 $833
2006-09-30 $1,102
2006-06-30 $14
2006-03-31 $1,001
2005-12-31 $824
2005-09-30 $967
2005-06-30 $1,029
2005-03-31 $854
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $130.351B $25.424B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.274B 9.51
CSL (CSLLY) Australia $96.573B 0.00
Gilead Sciences (GILD) United States $79.178B 8.89
Illumina (ILMN) United States $64.343B 98.00
Moderna (MRNA) United States $58.690B 0.00
Vertex Pharmaceuticals (VRTX) United States $55.127B 23.43
Regeneron Pharmaceuticals (REGN) United States $48.730B 15.93
Biogen (BIIB) United States $41.108B 8.22
Alexion Pharmaceuticals (ALXN) United States $33.059B 12.87
BeiGene (BGNE) Cayman Islands $28.033B 0.00
Seagen (SGEN) United States $27.847B 47.74
BioNTech SE (BNTX) Germany $25.278B 0.00
Exact Sciences (EXAS) United States $23.063B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.659B 0.00
Genmab (GMAB) Denmark $22.174B 31.04
Horizon Therapeutics Public (HZNP) Ireland $21.170B 24.29
Genmab (GNMSF) Denmark $20.868B 4.95
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Alnylam Pharmaceuticals (ALNY) United States $17.832B 0.00
Incyte (INCY) United States $17.271B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.884B 0.00
Guardant Health (GH) United States $15.529B 0.00
Bio-Techne Corp (TECH) United States $14.567B 83.43
BioMarin Pharmaceutical (BMRN) United States $14.166B 112.91
Novavax (NVAX) United States $13.113B 0.00
Zai Lab (ZLAB) China $13.028B 0.00
Repligen (RGEN) United States $11.647B 128.10
QIAGEN (QGEN) Netherlands $11.490B 23.47
Mirati Therapeutics (MRTX) United States $10.240B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.788B 0.00
Ultragenyx Pharmaceutical (RARE) United States $9.368B 0.00
Fate Therapeutics (FATE) United States $8.995B 0.00
Ascendis Pharma (ASND) Denmark $8.286B 0.00
Acceleron Pharma (XLRN) United States $8.226B 0.00
Denali Therapeutics (DNLI) United States $7.612B 242.00
ACADIA Pharmaceuticals (ACAD) United States $7.513B 0.00
Adaptive Biotechnologies (ADPT) United States $7.394B 0.00
Vir Biotechnology (VIR) United States $7.381B 0.00
Sarepta Therapeutics (SRPT) United States $7.018B 0.00
Twist Bioscience (TWST) United States $6.893B 0.00
Exelixis (EXEL) United States $6.867B 62.89
Halozyme Therapeutics (HALO) United States $6.089B 50.01
NeoGenomics (NEO) United States $6.033B 737.00
Blueprint Medicines (BPMC) United States $5.726B 18.85
Galapagos (GLPG) Belgium $5.518B 0.00
Certara (CERT) United States $5.429B 0.00
Beam Therapeutics (BEAM) United States $5.350B 0.00
Emergent Biosolutions (EBS) United States $5.293B 12.65
SWEDISH ORP BIO (BIOVF) Sweden $4.999B 15.72
Biohaven Pharmaceutical Holding (BHVN) United States $4.955B 0.00
China Biologic Products (CBPO) China $4.639B 30.06
Arena Pharmaceuticals (ARNA) United States $4.634B 0.00
Reata Pharmaceuticals (RETA) United States $4.412B 0.00
I-Mab (IMAB) China $4.238B 0.00
Intellia Therapeutics (NTLA) United States $4.197B 0.00
Berkeley Lights (BLI) United States $3.981B 0.00
Insmed (INSM) United States $3.962B 0.00
SpringWorks Therapeutics (SWTX) United States $3.820B 0.00
Arvinas (ARVN) United States $3.788B 0.00
Apellis Pharmaceuticals (APLS) United States $3.665B 0.00
Legend Biotech (LEGN) United States $3.469B 0.00
MorphoSys AG (MOR) Germany $3.346B 121.10
NantKwest (NK) United States $3.091B 0.00
Editas Medicine (EDIT) United States $3.078B 0.00
Alkermes (ALKS) Ireland $3.056B 0.00
Amicus Therapeutics (FOLD) United States $2.952B 0.00
Viela Bio (VIE) United States $2.906B 0.00
Intra-Cellular Therapies (ITCI) United States $2.787B 0.00
Global Blood Therapeutics (GBT) United States $2.737B 0.00
Sorrento Therapeutics (SRNE) United States $2.651B 0.00
Arcus Biosciences (RCUS) United States $2.571B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.553B 0.00
Ligand Pharmaceuticals (LGND) United States $2.539B 48.07
PHARMA MAR SA (PHMMF) Spain $2.433B 0.00
Amarin (AMRN) Ireland $2.345B 0.00
Morphic Holding (MORF) United States $2.306B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.252B 0.00
Genetron Holdings (GTH) China $2.213B 0.00
Myriad Genetics (MYGN) United States $2.153B 0.00
Vericel (VCEL) United States $2.150B 935.80
Inovio Pharmaceuticals (INO) United States $2.080B 0.00
Bluebird Bio (BLUE) United States $2.068B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.987B 16.45
NGM Biopharmaceuticals (NGM) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.866B 0.00
Revance Therapeutics (RVNC) United States $1.860B 0.00
Pandion Therapeutics (PAND) United States $1.808B 0.00
Scholar Rock Holding (SRRK) United States $1.795B 0.00
Seres Therapeutics (MCRB) United States $1.790B 0.00
Heska (HSKA) United States $1.788B 0.00
Precigen (PGEN) United States $1.765B 0.00
Zymeworks (ZYME) Canada $1.689B 0.00
Sangamo Therapeutics (SGMO) United States $1.666B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.625B 0.00
UniQure (QURE) Netherlands $1.601B 0.00
Castle Biosciences (CSTL) United States $1.598B 0.00
Frequency Therapeutics (FREQ) United States $1.592B 0.00
Antibe Therapeutics (ATBPF) Canada $1.571B 0.00
REGENXBIO (RGNX) United States $1.545B 0.00
Travere Therapeutics (TVTX) United States $1.490B 0.00
Bionano Genomics (BNGO) United States $1.452B 0.00
Zealand Pharma (ZEAL) Denmark $1.450B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.444B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.418B 0.00
Nurix Therapeutics (NRIX) United States $1.397B 0.00
Cytokinetics (CYTK) United States $1.381B 0.00
Alector (ALEC) United States $1.355B 0.00
Codexis (CDXS) United States $1.340B 0.00
Mersana Therapeutics (MRSN) United States $1.326B 0.00
Pliant Therapeutics (PLRX) United States $1.305B 0.00
MiMedx (MDXG) United States $1.239B 0.00
Northwest Biotherapeutics (NWBO) United States $1.233B 0.00
Avid Bioservices (CDMO) United States $1.225B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Adverum Biotechnologies (ADVM) United States $1.188B 0.00
Celldex Therapeutics (CLDX) United States $1.183B 0.00
Coherus BioSciences (CHRS) United States $1.145B 9.31
Protagonist Therapeutics (PTGX) United States $1.123B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.103B 0.00
Mesoblast (MESO) Australia $1.088B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.086B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.985B 41.74
G1 THERAPEUTICS (GTHX) United States $0.981B 0.00
Dynavax Technologies (DVAX) United States $0.979B 0.00
Epizyme (EPZM) United States $0.972B 0.00
Cara Therapeutics (CARA) United States $0.943B 236.25
Cellectis S.A (CLLS) France $0.941B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.940B 0.00
MannKind (MNKD) United States $0.934B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.900B 0.00
Prothena (PRTA) Ireland $0.868B 0.00
Sutro Biopharma (STRO) United States $0.864B 0.00
Five Prime Therapeutics (FPRX) United States $0.849B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.840B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
VBI Vaccines (VBIV) United States $0.804B 0.00
Kadmon Holdings (KDMN) United States $0.803B 0.00
ChromaDex (CDXC) United States $0.767B 0.00
Cel-Sci (CVM) United States $0.760B 0.00
AnaptysBio (ANAB) United States $0.755B 0.00
Merus (MRUS) Netherlands $0.751B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.715B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.708B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Agenus (AGEN) United States $0.696B 0.00
ALBIREO PHARMA (ALBO) United States $0.684B 0.00
Starpharma Holdings (SPHRY) Australia $0.679B 0.00
Precision BioSciences (DTIL) United States $0.646B 0.00
Compugen (CGEN) Israel $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Clovis Oncology (CLVS) United States $0.598B 0.00
Curis (CRIS) United States $0.596B 0.00
DBV Technologies S.A (DBVT) France $0.579B 0.00
Gritstone Oncology (GRTS) United States $0.565B 0.00
AC Immune SA (ACIU) Switzerland $0.555B 0.00
MeiraGTx Holdings (MGTX) United States $0.553B 0.00
Geron (GERN) United States $0.553B 0.00
Anika Therapeutics (ANIK) United States $0.543B 73.46
AMMO (POWW) United States $0.532B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
WAVE Life Sciences (WVE) Singapore $0.522B 0.00
AquaBounty Technologies (AQB) United States $0.521B 0.00
Amryt Pharma (AMYT) United Kingdom $0.518B 0.00
Syros Pharmaceuticals (SYRS) United States $0.515B 0.00
Athenex (ATNX) United States $0.503B 0.00
Affimed (AFMD) Germany $0.501B 0.00
Neoleukin Therapeutics (NLTX) United States $0.498B 0.00
Spero Therapeutics (SPRO) United States $0.487B 0.00
Fortress Biotech (FBIO) United States $0.458B 0.00
Selecta Biosciences (SELB) United States $0.456B 0.00
Kala Pharmaceuticals (KALA) United States $0.453B 0.00
Opthea (OPT) Australia $0.430B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 20.09
UROGEN PHARMA (URGN) United States $0.412B 0.00
Cardiff Oncology (CRDF) United States $0.411B 0.00
Verastem (VSTM) United States $0.404B 0.00
XOMA (XOMA) United States $0.399B 0.00
Athersys (ATHX) United States $0.397B 0.00
Puma Biotechnology (PBYI) United States $0.396B 0.00
Cue Biopharma (CUE) United States $0.394B 0.00
CytomX Therapeutics (CTMX) United States $0.386B 0.00
Forte Biosciences (FBRX) United States $0.378B 0.00
Oncobiologics (OTLK) United States $0.376B 0.00
IBio (IBIO) United States $0.372B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.372B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 9.30
Autolus Therapeutics (AUTL) United Kingdom $0.355B 0.00
Innate Pharma S.A (IPHA) France $0.355B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.346B 0.00
Trevena (TRVN) United States $0.341B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.328B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.326B 0.00
Arbutus Biopharma (ABUS) United States $0.325B 0.00
NextCure (NXTC) United States $0.319B 0.00
Theratechnologies (THTX) Canada $0.312B 0.00
Bellus Health (BLU) Canada $0.305B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.291B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Cerecor (CERC) United States $0.274B 0.00
Kamada (KMDA) Israel $0.272B 15.67
HOOKIPA Pharma (HOOK) United States $0.259B 0.00
Applied Genetic Technologies (AGTC) United States $0.248B 0.00
CorMedix Inc (CRMD) United States $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.245B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.242B 0.00
Aptinyx (APTX) United States $0.235B 0.00
OSMOTICA PHARM (OSMT) United States $0.234B 0.00
Abeona Therapeutics (ABEO) United States $0.233B 0.00
TELA Bio (TELA) United States $0.230B 0.00
Checkpoint Therapeutics (CKPT) United States $0.227B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Voyager Therapeutics (VYGR) United States $0.214B 5.97
Strongbridge Biopharma (SBBP) United States $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.200B 0.00
Exicure (XCUR) United States $0.199B 0.00
Idera Pharmaceuticals (IDRA) United States $0.199B 0.00
GENFIT S.A (GNFT) France $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
VolitionRX (VNRX) United States $0.194B 0.00
Pluristem Therapeutics (PSTI) Israel $0.194B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.188B 0.00
Palatin Technologies (PTN) United States $0.182B 0.00
Kindred Biosciences (KIN) United States $0.180B 0.00
Protalix BioTherapeutics (PLX) Israel $0.179B 0.00
Nicox SA (NICXF) France $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.174B 0.00
DiaMedica Therapeutics (DMAC) United States $0.172B 0.00
Orgenesis (ORGS) United States $0.171B 353.50
Clearside Biomedical (CLSD) United States $0.165B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.164B 0.00
Cogent Biosciences (COGT) United States $0.161B 0.00
Seelos Therapeutics (SEEL) United States $0.161B 0.00
Evogene (EVGN) Israel $0.152B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Dyadic (DYAI) United States $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
Aptevo Therapeutics (APVO) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.142B 0.00
Aytu Bioscience (AYTU) United States $0.140B 0.00
Synlogic (SYBX) United States $0.139B 0.00
TRACON Pharmaceuticals (TCON) United States $0.138B 0.00
Liminal BioSciences (LMNL) Canada $0.138B 0.00
Cyclerion Therapeutics (CYCN) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.135B 0.00
Prima BioMed (IMMP) Australia $0.132B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.129B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Beyond Air (XAIR) United States $0.119B 0.00
CytRx (CYTR) United States $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
Cocrystal Pharma (COCP) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.109B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
Ecology Coatings (ABVC) United States $0.106B 0.00
AIkido Pharma (AIKI) United States $0.099B 0.00
Novogen (KZIA) Australia $0.096B 0.00
Vascular Biogenics (VBLT) Israel $0.094B 0.00
Advaxis (ADXS) United States $0.093B 0.00
Stealth BioTherapeutics (MITO) United States $0.093B 41.75
Adocia (ADOCY) France $0.092B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
Windtree Therapeutics (WINT) United States $0.084B 0.00
AEterna Zentaris (AEZS) United States $0.082B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Cleveland BioLabs (CBLI) United States $0.081B 0.00
Celsion (CLSN) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Purple Biotech (PPBT) Israel $0.070B 0.00
Viracta Therapeutics (VIRX) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.066B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
ARIDIS PHARMACT (ARDS) United States $0.065B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
Pulmatrix (PULM) United States $0.060B 0.00
Enveric Biosciences (ENVB) United States $0.055B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.049B 0.00
BioCardia (BCDA) United States $0.049B 0.00
Yumanity Therapeutics (YMTX) United States $0.047B 0.00
ATyr Pharma (LIFE) United States $0.046B 0.00
Alimera Sciences (ALIM) United States $0.046B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.037B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Timber Pharmaceuticals (TMBR) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Seneca Biopharma (SNCA) United States $0.024B 0.00
ThermoGenesis Holdings (THMO) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Benitec Biopharma (BNTC) United States $0.015B 0.00
Cyclo Therapeutics (CYTH) United States $0.014B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00